NCT02134366View on ClinicalTrials.gov

Clobazam Use in Epilepsia Partialis Continua - Pilot Study

PHASE3TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Epilepsia Partialis ContinuaKojewnikov's EpilepsyEpilepsy
Interventions
DRUG

Clobazam

Comparison of AED use in Epilepsia Partialis Continua

DRUG

Clonazepam

Comparison of AED use in Epilepsia Partialis Continua

DRUG

Lorazepam

Comparison of AED use in Epilepsia Partialis Continua

Trial Locations (1)

08103

Cooper Universtiy Hospital, Camden

Sponsors

Collaborators (1)

Lundbeck LLC
All Listed Sponsors
collaborator

Lundbeck LLC

INDUSTRY

lead

The Cooper Health System

OTHER

NCT02134366 - Clobazam Use in Epilepsia Partialis Continua - Pilot Study | Biotech Hunter | Biotech Hunter